Effective Clinician-Patient Partnering in IPF

This interactive, online activity is intended for pulmonologists, primary care physicians with a high volume of patients with pulmonary disease; physician assistants, nurse practitioners, and nurses involved in the diagnosis and management of patients with idiopathic pulmonary fibrosis (IPF)

Activity Information


Original Release Date: February 2018
Expiration Date: February 28, 2019
Estimated Time to Complete Activity: .50 hours




James E. Loyd, MD ~ Moderator
Rudy W. Jacobson Chair in Pulmonary Medicine
and Professor of Medicine
Division of Allergy, Pulmonary, and Critical Care Medicine
Vanderbilt University Medical Center
Nashville, TN

Lisa Boyd
Idiopathic Pulmonary Fibrosis (IPF) Caregiver
Chicago, IL

Tina H. Givens, BS, RRT
Registered Respiratory Therapist
University of Alabama Hospital
Birmingham, AL

Fred Haley
Patient with IPF
Chicago, IL

Heather Kagel
Patient with IPF
Dallas, TX

Wendi R. Mason, MSN, ACNP-BC
Assistant in Medicine, Nurse Practitioner
Division of Allergy, Pulmonary, and Critical Care Medicine
Vanderbilt University Medical Center
Nashville, TN

Barbara Murphy
Lung Transplant Recipient
Cranford, NJ

Michele Peters
IPF Caregiver
Streamwood, IL

Method of Participation

Participants should read the CME/CE information, review the activity in its entirety, and complete the online post-test and evaluation. Upon completing this activity as designed and achieving a passing score on the post-test, you will be directed to a Web page that will allow you to receive your certificate of credit via e-mail or you may print it out at that time.
The online post-test and evaluation can be accessed at:

Inquiries may be directed to Global Academy for Medical Education at
info@globalacademycme.com or (973) 290-8225.

Learning Objectives

  • Demonstrate communication techniques for use with IPF patients that include effective disease-state education.
  • Describe the relationship between delayed referral of patients with IPF to tertiary care and reduced survival.
  • Identify the degree of impact of IPF on patients’ quality of life.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Disclosure Declarations

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Faculty Disclosures

Faculty Member

Reported Financial Relationship

James E. Loyd, MD

Has nothing to disclose.

Wendi R. Mason, MSN, ACNP-BC

Consultant: Genentech-Roche, Boehringer Ingelheim

Tina H. Givens, BS, RRT

Has nothing to disclose.

Patients and Caregivers: Fred Haley, Michele Peters, Lisa Boyd, Barbara Murphy, and Heather Kagel

Have nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Contact Information for Technical Questions

Please technical questions or concerns to Global Academy for Medical Education at 973-290-8225 or email info@globalacademycme.com.

Copyright Statement

Copyright © 2018 by Global Academy for Medical Education, LLC, Frontline Medical Communications Inc., and its Licensors. All rights reserved. No part of this publication may be reproduced or transmitted in any form, by any means, without prior written permission of the Publisher. Global Academy for Medical Education, LLC, will not assume responsibility for damages, loss, or claims of any kind arising from or related to the information contained in this publication, including any claims related to the products, drugs, or services mentioned herein